Pharmaceutical Compounds, Devices for Disease Treatment
Summary
USPTO Application US20260109677A1, filed December 8, 2025, discloses compounds of Formula (I) and implantable devices comprising those compounds, with methods of use for treating or preventing diseases, disorders, or conditions. Inventors include Omid Veiseh, Richard Heidebrecht, Paul Kevin Wotton, Matthias Alexander Oberli, and Robert James Miller. CPC classifications span C07D, A61K, A61P, C07F, C07H, C07K, C12N, and C12Y technical areas.
“The present invention provides compounds, e.g., compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof.”
About this source
GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 258 changes logged to date.
What changed
USPTO published patent application US20260109677A1 on April 23, 2026. The application discloses compounds of Formula (I), including pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof, as well as implantable elements such as devices and materials incorporating these compounds, along with methods of use for treating or preventing diseases, disorders, or conditions.
The publication represents a new patent application in the pharmaceutical and medical device fields. Competitors developing therapeutic compounds or implantable devices in related technical areas (as identified by the CPC classifications covering triazoles, heterocyclic compounds, saccharides, enzymes, and antibodies) may wish to review the application's claims for potential overlap with their own R&D programs. No compliance deadlines or obligations are imposed by this publication.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOUNDS, DEVICES, AND USES THEREOF
Application US20260109677A1 Kind: A1 Apr 23, 2026
Inventors
Omid Veiseh, Richard Heidebrecht, Paul Kevin Wotton, Matthias Alexander Oberli, Robert James Miller
Abstract
The present invention provides compounds, e.g., compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are implantable elements (e.g., devices and materials) comprising the same, as well as methods of use thereof, e.g., for treating or preventing a disease, disorder, or condition.
CPC Classifications
C07D 249/04 A61K 9/0019 A61K 31/4192 A61K 31/54 A61K 31/541 A61K 31/695 A61K 31/7056 A61K 35/30 A61K 38/47 A61K 39/3955 A61P 37/04 A61P 37/06 C07D 295/088 C07D 403/12 C07D 405/12 C07D 405/14 C07D 409/04 C07F 7/1804 C07F 7/1892 C07H 15/26 C07K 16/22 C12N 9/2465 C12Y 302/01022
Filing Date
2025-12-08
Application No.
19412601
Parties
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.